» Articles » PMID: 22162568

Insulin- and Obesity-related Variables in Early-stage Breast Cancer: Correlations and Time Course of Prognostic Associations

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2011 Dec 14
PMID 22162568
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate patterns of prognostic associations over time of insulin- and obesity-related variables measured at diagnosis of early breast cancer (BC), focusing on whether the prognostic associations with distant recurrence and death changed over time.

Patients And Methods: Five hundred thirty-five nondiabetic women with T1-3, N0-1, M0 invasive BC diagnosed from 1989 to 1996 were included in the study. Insulin-related variables included fasting insulin, Homeostasis Model Assessment, C-peptide, and glucose. Obesity-related variables included weight, body mass index (BMI), waist and hip circumference, and leptin. Correlations were examined using the Pearson correlation coefficient and prognostic associations using the Cox model.

Results: There was evidence that associations of baseline insulin-related variables with distant recurrence and death were not constant over time; univariable adverse prognostic associations were significant only during the first 5 years (eg, insulin quartile 4 v 1: hazard ratio [HR], 2.32; 95% CI, 1.39 to 3.86; P < .001 for distant disease-free survival [DDFS]; and HR, 2.85; 95% CI, 1.48 to 5.50; P = .002 for overall survival [OS], with little attenuation of this pattern in multivariable analyses). In contrast, obesity-related variables (BMI, weight, leptin) exerted significant adverse univariable associations that were constant over time (eg, BMI quartile 4 v 2: HR, 1.40; 95% CI, 1.07 to 1.82 for DDFS; P = .014; and HR, 1.50; 95% CI, 1.16 to 1.93; P < .001 for OS); prognostic associations of leptin remained significant in multivariable analyses.

Conclusion: Baseline insulin- and obesity-related variables exert different patterns of prognostic associations over time in early BC.

Citing Articles

Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.

Engin A Adv Exp Med Biol. 2024; 1460:767-819.

PMID: 39287872 DOI: 10.1007/978-3-031-63657-8_26.


Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer.

Javed S, Skolariki A, Zameer M, Lord S Br J Cancer. 2024; 131(11):1724-1736.

PMID: 39251829 PMC: 11589622. DOI: 10.1038/s41416-024-02833-1.


Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions.

Xu K, Fu A, Li Z, Miao L, Lou Z, Jiang K Nat Commun. 2024; 15(1):1685.

PMID: 38402239 PMC: 10894219. DOI: 10.1038/s41467-024-45995-5.


WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Adiponectin and Leptin Levels in Breast Cancer Survivors with Overweight or Obesity.

Lin D, Sturgeon K, Gordon B, Brown J, Sears D, Sarwer D Nutrients. 2023; 15(15).

PMID: 37571390 PMC: 10421485. DOI: 10.3390/nu15153453.


Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.

Ruggieri L, Moretti A, Berardi R, Cona M, Dalu D, Villa C Int J Mol Sci. 2023; 24(5).

PMID: 36902406 PMC: 10002538. DOI: 10.3390/ijms24054974.